Last 130.70 INR
Change Today -0.90 / -0.68%
Volume 25.9K
PNCB On Other Exchanges
Symbol
Exchange
Natl India
As of 6:06 AM 02/28/15 All times are local (Market data is delayed by at least 15 minutes).

panacea biotec ltd (PNCB) Snapshot

Open
135.00
Previous Close
131.60
Day High
135.00
Day Low
130.10
52 Week High
09/22/14 - 219.35
52 Week Low
03/14/14 - 89.70
Market Cap
8.0B
Average Volume 10 Days
35.0K
EPS TTM
-18.31
Shares Outstanding
61.3M
EX-Date
09/19/11
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PANACEA BIOTEC LTD (PNCB)

Related News

No related news articles were found.

panacea biotec ltd (PNCB) Related Businessweek News

No Related Businessweek News Found

panacea biotec ltd (PNCB) Details

Panacea Biotec Limited, a health management company, researches and develops, manufactures, and markets pharmaceuticals, biopharmaceuticals, vaccines, and natural/indigenous products in India and internationally. Its product portfolio includes prescription products in various therapeutic areas, including pain management, diabetes and cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, and gastro-intestinal care and vaccines. The company has collaboration agreements with The Institute for Translational Vaccinology (Intravacc), the Netherlands; JSC Binnopharm Inc., Russia; National Institute of Immunology, India; Dr. Reddy’s Laboratories Limited; PT BioFarma, Indonesia; and Kremers Urban Inc., as well as strategic alliance with Apotex Inc. Panacea Biotec Limited was founded in 1984 and is based in New Delhi, India.

2,750 Employees
Last Reported Date: 08/27/14
Founded in 1984

panacea biotec ltd (PNCB) Top Compensated Officers

Managing Director, Director and Member of Sta...
Total Annual Compensation: 7.2M
Joint Managing Director and Whole-Time Direct...
Total Annual Compensation: 6.0M
Joint Managing Director and Director
Total Annual Compensation: 5.6M
Founder and Chairman
Total Annual Compensation: 7.2M
Director of Operations & Projects, Whole-Time...
Total Annual Compensation: 2.5M
Compensation as of Fiscal Year 2014.

panacea biotec ltd (PNCB) Key Developments

Panacea Biotec Ltd Gets Pan American Health Organization Order for Supply of EasyFive-TT Vaccines

Panacea Biotec Ltd. has informed that the company has been elected for supply of Pentavalent Vaccine DTP-HepB-Hib by Pan American Health Organization (PAHO). The company has been awarded for supply of 5.99 million doses of EasyFive-TT (DTP-HepB-Hib) fully liquid Pentavalent Vaccine for calendar year 2015 & 2016 worth USD 13.49 million to meet the requirements of global immunization program.

Panacea Biotec Ltd. to Report Q3, 2015 Results on Feb 13, 2015

Panacea Biotec Ltd. announced that they will report Q3, 2015 results on Feb 13, 2015

Panacea Biotec Ltd., Board Meeting, Feb 13, 2015

Panacea Biotec Ltd., Board Meeting, Feb 13, 2015. Agenda: To consider and approve the unaudited financial results (provisional) for the quarter ended December 31, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PNCB:IN 130.70 INR -0.90

PNCB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
GlaxoSmithKline PLC 1,542 GBp -12.50
Johnson & Johnson $102.51 USD -0.29
Novartis AG SFr.97.45 CHF -0.70
Pfizer Ltd/India 1,993 INR -26.00
Sanofi India Ltd 3,333 INR +24.20
View Industry Companies
 

Industry Analysis

PNCB

Industry Average

Valuation PNCB Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PANACEA BIOTEC LTD, please visit www.panacea-biotec.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.